SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16567811
Source:
http://linkedlifedata.com/resource/pubmed/id/16567811
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011860
,
umls-concept:C0025598
,
umls-concept:C0030705
,
umls-concept:C0036043
,
umls-concept:C0205314
,
umls-concept:C0332307
,
umls-concept:C0679622
pubmed:issue
4
pubmed:dateCreated
2006-3-28
pubmed:abstractText
The purpose of this study was to determine the efficacy and safety of a novel extended-release metformin in patients with type 2 diabetes.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose
,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations
,
http://linkedlifedata.com/resource/pubmed/chemical/Fructosamine
,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Metformin
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0149-5992
pubmed:author
pubmed-author:BernerBretB
,
pubmed-author:ChiangYu-KunYK
,
pubmed-author:CramerMarilouM
,
pubmed-author:FonsecaVivianV
,
pubmed-author:LewinAndrewA
,
pubmed-author:SchwartzSherwynS
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
759-64
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16567811-Adolescent
,
pubmed-meshheading:16567811-Adult
,
pubmed-meshheading:16567811-Aged
,
pubmed-meshheading:16567811-Blood Glucose
,
pubmed-meshheading:16567811-Delayed-Action Preparations
,
pubmed-meshheading:16567811-Diabetes Mellitus, Type 2
,
pubmed-meshheading:16567811-Dose-Response Relationship, Drug
,
pubmed-meshheading:16567811-Double-Blind Method
,
pubmed-meshheading:16567811-Female
,
pubmed-meshheading:16567811-Fructosamine
,
pubmed-meshheading:16567811-Hemoglobin A, Glycosylated
,
pubmed-meshheading:16567811-Humans
,
pubmed-meshheading:16567811-Hypoglycemic Agents
,
pubmed-meshheading:16567811-Male
,
pubmed-meshheading:16567811-Metformin
,
pubmed-meshheading:16567811-Middle Aged
pubmed:year
2006
pubmed:articleTitle
Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes.
pubmed:affiliation
Diabetes and Glandular Disease Research Associates, San Antonio, Texas, USA.
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase III